Tumor-associated macrophages (TAMs) are abundant in near all solid tumors and are
involved in many aspects of cancer progression. The presence of TAMs is negative …

Tumor-associated macrophages (TAMs) are abundant in near all solid tumors and are
involved in many aspects of cancer progression. The presence of TAMs is negative …

Tumor-associated macrophages (TAMs) are abundant in pancreatic ductal
adenocarcinomas (PDACs). While TAMs are known to proliferate in cancer tissues, the …

Monocytes and macrophages make up part of the innate immune system and provide one of
the first defenses against variety of treats. Macrophages can also modulate the adaptive …

Tumor-associated macrophages (TAMs) are involved in many aspects of cancer progression
and correlate with poor clinical outcomes in many cancer types, including pancreatic ductal …

During cancer progression, bone marrow derived myeloid cells, including immature myeloid
cells and macrophages, progressively accumulate at the primary tumour site where they …

Tumor-associated macrophages (TAMs) are essential components of the cancer
microenvironment and play critical roles in the regulation of tumor progression. Optimal …

Pancreatic cancer has an overall 5-year survival rate of less than 5%. Unfortunately, patient
survival has not substantially improved in the last couple of decades despite advances in …

Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy. PDAC is only
cured by surgical resection in its early stage, but there remains a relatively high possibility of …

Objective Tumour-associated macrophages (TAMs) play key roles in tumour progression.
Recent evidence suggests that TAMs critically modulate the efficacy of anticancer therapies …